The role of systemic and targeted therapies in brain metastases

被引:5
|
作者
Franceschi, Enrico [1 ]
Bartolotti, Marco [1 ]
Poggi, Rosalba [1 ]
Di Battista, Monica [1 ]
Palleschi, Dario [1 ]
Brandes, Alba A. [1 ]
机构
[1] Azienda USL Bologna, Bellaria Maggiore Hosp, Dept Med Oncol, I-40139 Bologna, Italy
关键词
BRAF V600E melanoma; brain metastases; EGFR mutations; HER2 breast cancer; target therapy; CELL LUNG-CANCER; LAPATINIB PLUS CAPECITABINE; PHASE-II TRIAL; TYROSINE KINASE INHIBITORS; EARLY BREAST-CANCER; RADIATION-THERAPY; OPEN-LABEL; INTRACRANIAL METASTASES; ADJUVANT TRASTUZUMAB; CEREBRAL METASTASES;
D O I
10.1586/14737140.2014.856760
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
For many years, brain metastases (BMs) have been considered as the final stage of a disease course and engendered skepticism about the efficacy of treatments. Local treatments, mainly, whole-brain radiotherapy have been the standard of care, whereas chemotherapy has been considered of limited efficacy due to the potential role of blood-brain barrier.
引用
收藏
页码:93 / 103
页数:11
相关论文
共 50 条
  • [31] Radiotherapy in combination with systemic therapies for brain metastases: current status and progress
    Lei Liu
    Wanqi Chen
    Ruopeng Zhang
    Yuekun Wang
    Penghao Liu
    Xin Lian
    Fuquan Zhang
    Yu Wang
    Wenbin Ma
    Cancer Biology & Medicine, 2020, 17 (04) : 910 - 922
  • [32] Available Systemic Treatments and Emerging Therapies for Breast Cancer Brain Metastases
    Rader, Ryan K.
    Anders, Carey K.
    Lin, Nancy U.
    Sammons, Sarah L.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (06) : 611 - 627
  • [33] Concurrent Radiosurgery and Systemic Therapies for Melanoma Brain Metastases: A Systematic Review
    Weaver, Bradley D.
    Goodman, James R.
    Jensen, Randy
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (11)
  • [34] Available Systemic Treatments and Emerging Therapies for Breast Cancer Brain Metastases
    Ryan K. Rader
    Carey K. Anders
    Nancy U. Lin
    Sarah L. Sammons
    Current Treatment Options in Oncology, 2023, 24 : 611 - 627
  • [35] Radiotherapy in combination with systemic therapies for brain metastases: current status and progress
    Lei Liu
    Wanqi Chen
    Ruopeng Zhang
    Yuekun Wang
    Penghao Liu
    Xin Lian
    Fuquan Zhang
    Yu Wang
    Wenbin Ma
    Cancer Biology & Medicine , 2020, (04) : 910 - 922
  • [36] Brain metastases in metastatic cancer: a review of recent advances in systemic therapies
    Steindl, Ariane
    Berghoff, Anna S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (03) : 325 - 339
  • [37] Targeted therapies for systemic sclerosis
    Denton, Christopher P.
    Ong, Voon H.
    NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (08) : 451 - 464
  • [38] Upfront radiotherapy in not mandatory in patients with brain metastases treatable with immunotherapy or targeted therapies
    Soffeti, R.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S5 - S5
  • [39] Prognostic factors of brain metastases from breast cancer: Impact of targeted therapies
    Braccini, Antoine Laurent
    Azria, David
    Thezenas, Simon
    Romieu, Gilles
    Ferrero, Jean Marc
    Jacot, William
    BREAST, 2013, 22 (05): : 993 - 998
  • [40] Targeted therapies in systemic vasculitis
    Stone, JH
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2002, 69 (05) : 124 - 128